Status:
COMPLETED
Ultrasound Guided Thoracic Paravertebral Block for Hepatic Tumors Ablation
Lead Sponsor:
Mahidol University
Collaborating Sponsors:
Siriraj Hospital
Conditions:
Liver Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients undergo percutaneous radiofrequency ablation of hepatic tumors at Siriraj hospital normally receive only intravenous sedative drugs which sometimes can not provide effective pain control. TP...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Patients undergo percutaneous radiofrequency ablation for liver tumors
- ASA classification 1-3
Exclusion
- Psychiatric illness
- Chronic abdominal pain \> 1 week
- Regular analgesic drugs use
- Infection at back (Block area)
- Severe spinal deformity
- PT \> 16 sec, aPTT \> 32, platelet \< 50,000/cumm
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT02271646
Start Date
August 1 2014
End Date
March 1 2015
Last Update
March 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Siriraj hospital
Bangkok, Thailand, 10700